Showing 1-5 of 5 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| microRNA-146a is a potential therapeutic target for type 1 diabetes | Case Western Reserve University | Parameswaran Ramakrishnan | Cures | 01-June-2024 to 31-May-2027 | $600,000.00 |
| Novel mechanism and method to control T cell mediated autoimmunity in type 1 diabetes | Case Western Reserve University | Parameswaran Ramakrishnan | Cures | 01-June-2022 to 31-May-2027 | $600,000.00 |
| Acute Hyperglycemia Promotes a Proinflammatory Monocyte Phenotype to Drive Glomerular Injury in People with Diabetic Kidney Disease and Type 1 Diabetes | Cleveland Clinic Foundation | Rong Mei Zhang | Improving Lives | 01-July-2026 to 31-December-2027 | $74,999.40 |
| Treatment of type-1 diabetes with apolipoprotein A4 – efficacy and mechanisms | University of Cincinnati | Min Liu | Cures | 01-March-2023 to 28-February-2027 | $721,291.00 |
| Charting a Path for Continuous Insulin Monitoring | University of Cincinnati | Ryan White | Improving Lives | 01-April-2024 to 31-March-2027 | $708,147.00 |